moxalactam has been researched along with Deficiency, Factor II in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipsky, JJ | 2 |
| Buening, MK; Hanasono, GK; Wold, JS | 1 |
| Reitan, J; Seeler, RA | 1 |
| Mielke, CH; Pakter, RL; Russell, TR; West, D | 1 |
| Panwalker, AP; Rosenfeld, J | 1 |
| D'Elia, JA; Kaldany, A; Kaye, WA; Miller, DG; Yoburn, DC | 1 |
| Lewis, JC; Lipsky, JJ; Novick, WJ | 1 |
| Bow, EJ; Chubb, H; Conly, JM; Louie, TJ; Ramotar, K | 1 |
| Gorrochategui, M; Holt, RJ; Perez, C | 1 |
| Ballard, JO; Joehl, RJ; Rasbach, DA; Sattler, FR; Weitekamp, MR | 1 |
| Clark, J; D'Elia, JA; Hochman, R; Kaldany, A; Miller, DG; Rolla, AR; Thomas, S | 1 |
| Albin, H; Dabadie, H; Haramburu, F; Paccalin, J; Ragnaud, JM; Woné, C | 1 |
| Bailie, GR; Kravitz, GR; Smith, TR; Sylvester, RK | 1 |
| Harauchi, T; Matsubara, T; Takano, K; Touchi, A; Yoshizaki, T | 1 |
| Kobayashi, F; Matsubara, T; Matsuura, M; Satoh, S; Uchida, K | 2 |
| Gallego, MO; Kerremans, AL; Lipsky, JJ; Van Loon, J; Weinshilboum, RM | 1 |
| Adelman, MH; Grasela, TH; Rigan, D; Schentag, JJ; Welage, LS; Williams, JS; Wilton, JH | 1 |
| Danziger, LH; Ferron, JL; Gauderer, MW; Gordon, N; Hau, T; Stellato, TA | 1 |
| Goldstein, NH | 1 |
| Adelman, MH; Grasela, TH; Schentag, JJ; Welage, LS | 1 |
| Hosutt, JA; Lentnek, AL; McDevitt, JT; Nichols, RL; Wikler, MA | 1 |
| Hughes, JD; Nichols, C; Sanburg, AL | 1 |
| Conri, C; Fleury, B; Haramburu, F; Hervy, G; Koch, M | 1 |
3 review(s) available for moxalactam and Deficiency, Factor II
| Article | Year |
|---|---|
Cephalosporin induced coagulopathies.
Topics: Adult; Aged; Bleeding Time; Blood Platelet Disorders; Cephalosporins; Child; Humans; Hypoprothrombinemias; Infant; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Vitamin K 1; Vitamin K Deficiency | 1984 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
Determinants of antibiotic-associated hypoprothrombinemia.
Topics: Animals; Anti-Bacterial Agents; Blood Coagulation; Cephalosporins; Humans; Hypoprothrombinemias; In Vitro Techniques; Moxalactam; Risk; Tetrazoles | 1987 |
4 trial(s) available for moxalactam and Deficiency, Factor II
| Article | Year |
|---|---|
Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacteroides; Drug Therapy, Combination; Escherichia coli; Feces; Hemorrhagic Disorders; Humans; Hypoprothrombinemias; Intestines; Moxalactam; Neoplasms; Neutropenia; Prothrombin Time; Ticarcillin; Tobramycin | 1984 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
Analysis of prothrombin time prolongation in North American cefotetan clinical trials: questions and answers.
Topics: Cefotetan; Cefoxitin; Ceftriaxone; Cephamycins; Clinical Trials as Topic; Humans; Hypoprothrombinemias; Moxalactam; Prothrombin Time | 1988 |
Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Ceftizoxime; Cephalosporins; Double-Blind Method; Female; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Prothrombin Time; Random Allocation | 1987 |
19 other study(ies) available for moxalactam and Deficiency, Factor II
| Article | Year |
|---|---|
N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia.
Topics: Animals; Anti-Bacterial Agents; Azoles; Bacteria; Biotransformation; Cefamandole; Cefoperazone; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Glutamates; Glutamic Acid; Humans; Hypoprothrombinemias; Intestines; Moxalactam; Prothrombin; Rats; Structure-Activity Relationship; Tetrazoles | 1983 |
Latamoxef-associated hypoprothrombinaemia.
Topics: Animals; Cephalosporins; Cephamycins; Dogs; Humans; Hypoprothrombinemias; Moxalactam; Rats | 1983 |
Latamoxef-associated hypoprothrombinaemia.
Topics: Animals; Cephalosporins; Cephamycins; Humans; Hypoprothrombinemias; Kinetics; Moxalactam | 1983 |
Coagulopathy associated with the use of moxalactam.
Topics: Abdomen; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Hypoprothrombinemias; Male; Moxalactam; Vitamin K | 1982 |
Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam.
Topics: Aged; Bacterial Infections; Cephalosporins; Cephamycins; Diarrhea; Hemorrhage; Humans; Hypoprothrombinemias; Middle Aged; Moxalactam | 1983 |
Moxalactam, bleeding, and renal insufficiency.
Topics: Bacteria; Cephalosporins; Cephamycins; Humans; Hypoprothrombinemias; Intestines; Kidney Diseases; Moxalactam; Nephrectomy; Vitamin K | 1983 |
Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats.
Topics: Administration, Oral; Animals; Azoles; Cefotaxime; Female; Hypoprothrombinemias; Injections, Intravenous; Moxalactam; Prothrombin Time; Rats; Rats, Inbred Strains; Tetrazoles; Vitamin K Deficiency | 1984 |
Hypoprothrombinemia associated with moxalactam treatment of a septic sternoclavicular arthritis due to Citrobacter diversus.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cephalosporins; Cephamycins; Citrobacter; Enterobacteriaceae Infections; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Sternoclavicular Joint | 1981 |
Moxalactam. Evaluation of clinical bleeding in patients with abdominal infection.
Topics: Abdomen; Adult; Aged; Bacterial Infections; Bleeding Time; Evaluation Studies as Topic; Female; Hemorrhage; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Platelet Count; Prospective Studies | 1983 |
Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Blood Coagulation Disorders; Cephalosporins; Female; Humans; Hypoprothrombinemias; Kidney Failure, Chronic; Male; Middle Aged; Moxalactam; Peritoneal Dialysis; Prothrombin Time; Renal Dialysis | 1983 |
[3 new cases of hypoprothrombinemia induced by latamoxef].
Topics: Adult; Aged; Female; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam | 1984 |
Moxalactam-induced hypoprothrombinemia with intrahepatic bleeding.
Topics: Female; Hemorrhage; Humans; Hypoprothrombinemias; Liver Diseases; Middle Aged; Moxalactam | 1984 |
Depression of liver microsomal vitamin K epoxide reductase activity associated with antibiotic-induced coagulopathy.
Topics: Animals; Anti-Bacterial Agents; Blood Coagulation; Hypoprothrombinemias; Male; Microsomes, Liver; Mixed Function Oxygenases; Moxalactam; Rats; Rats, Inbred Strains; Vitamin K Deficiency; Vitamin K Epoxide Reductases | 1989 |
Vitamin K-reversible hypoprothrombinemia in rats: comparison of hypoprothrombinemic changes in various strains of rats caused by vitamin K deficiency and antibiotic treatment.
Topics: Animals; Blood Coagulation Tests; Female; Hematologic Tests; Hemorrhage; Hypoprothrombinemias; Leukocyte Count; Male; Moxalactam; Rats; Rats, Inbred F344; Rats, Inbred Strains; Sex Factors; Species Specificity; Vitamin K Deficiency | 1989 |
Cephalosporin-induced hypoprothrombinemia: possible role for thiol methylation of 1-methyltetrazole-5-thiol and 2-methyl-1,3,4-thiadiazole-5-thiol.
Topics: Animals; Azoles; Biotransformation; Carbon-Carbon Ligases; Cephalosporins; Chromatography, High Pressure Liquid; Glutamates; Glutamic Acid; Humans; Hypoprothrombinemias; Kidney; Kinetics; Ligases; Male; Methylation; Methyltransferases; Microsomes, Liver; Moxalactam; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Tetrazoles; Thiadiazoles | 1985 |
Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety.
Topics: Azoles; Cefoperazone; Cefotetan; Cephalosporins; Cephamycins; Humans; Hypoprothrombinemias; Moxalactam; Population Surveillance; Risk Factors; Tetrazoles | 1988 |
Vitamin K reversible hypoprothrombinemia in rats. II. Efficacy of vitamin K on latamoxef-induced coagulopathy in rats.
Topics: Animals; Blood Coagulation Tests; Female; Hypoprothrombinemias; Moxalactam; Rats; Rats, Inbred Strains; Vitamin K; Vitamin K Deficiency | 1988 |
Antibiotic-induced hypoprothrombinaemia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cefamandole; Escherichia coli Infections; Humans; Hypoprothrombinemias; Male; Moxalactam; Prothrombin Time; Urinary Tract Infections; Vitamin K | 1985 |
[Hemorrhagic complication caused by hypoprothrombinemia due to latamoxef].
Topics: Aged; Hemorrhage; Humans; Hypoprothrombinemias; Male; Moxalactam | 1985 |